Literature DB >> 2843379

Role of alpha-adrenoceptor subtypes mediating sympathetic vasoconstriction in human digits.

J D Coffman1, R A Cohen.   

Abstract

The effects of intra-arterial administration of alpha-1 and alpha-2 adrenoceptor agonists and antagonists on human digital blood flow were studied before and during reflex sympathetic vasoconstriction in normal subjects. Total finger flow was measured by venous occlusion air plethysmography and capillary flow by the disappearance rate of a radioisotope from a local injection in a fingerpad. Intra-arterial phenylephrine (0.2-1.3 micrograms min-1) and clonidine (0.12-0.48 micrograms min-1) produced dose-related decreases in finger blood flow and increases in vascular resistance. Clonidine was the more potent vasoconstrictor. Prazosin (0.4-3 micrograms min-1) effectively blocked the vasoconstrictor effect of phenylephrine but not clonidine, while yohimbine (30-70 micrograms min-1) blocked the effect of clonidine but not phenylephrine. In a 20 degrees C room, prazosin (0.4-13.2 micrograms min-1) caused no significant changes in finger blood flow (7.7 +/- 2.1 to 11.7 +/- 3.3 ml min-1 100 ml-1) or vascular resistance (30.9 +/- 8.8 to 28.1 +/- 8.7 mmHg ml-1 min-1 100 ml-1). In the 20 degrees C room, yohimbine (30-70 micrograms min-1) produced a significant increase in finger blood flow (7.8 +/- 2.8 to 23.4 +/- 6.8 ml, P less than 0.01) and decrease in vascular resistance (20.5 +/- 5.7 to 6.0 +/- 2.2 units, P less than 0.01). No significant changes occurred in finger capillary flow with prazosin or yohimbine infusions. It is concluded that alpha-1 and alpha-2 adrenoceptors are present in human digital vasculature and that alpha-2 adrenoceptors are more important than alpha-1 adrenoceptors in sympathetic neural vasoconstriction.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2843379     DOI: 10.1111/j.1365-2362.1988.tb01264.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  8 in total

Review 1.  Raynaud's phenomenon: epidemiology and risk factors.

Authors:  Liana Fraenkel
Journal:  Curr Rheumatol Rep       Date:  2002-04       Impact factor: 4.592

Review 2.  The pathogenesis, diagnosis and treatment of Raynaud phenomenon.

Authors:  Ariane L Herrick
Journal:  Nat Rev Rheumatol       Date:  2012-07-10       Impact factor: 20.543

Review 3.  Pathogenesis and treatment of Raynaud's phenomenon.

Authors:  J D Coffman
Journal:  Cardiovasc Drugs Ther       Date:  1990-01       Impact factor: 3.727

4.  Gender differences in modulation of peripheral vascular adrenoceptors.

Authors:  R R Freedman; M Moten
Journal:  Ann Behav Med       Date:  1995-03

Review 5.  A vascular mechanistic approach to understanding Raynaud phenomenon.

Authors:  Nicholas A Flavahan
Journal:  Nat Rev Rheumatol       Date:  2014-12-23       Impact factor: 20.543

6.  Metabolic heat production and cardiovascular responses to an incremental intravenous infusion of adrenaline in healthy subjects.

Authors:  D G Maggs; I W Gallen; K Fone; I A Macdonald
Journal:  Clin Auton Res       Date:  1994-06       Impact factor: 4.435

7.  Effects of cyclooxygenase inhibition on vascular responses evoked in fingers of men and women by iontophoresis of 1- and 2-adrenoceptor agonists.

Authors:  Amar Srinivasa; Janice M Marshall
Journal:  J Physiol       Date:  2011-08-01       Impact factor: 5.182

8.  Differential regulation of nitric oxide synthase function in aorta and tail artery from 5/6 nephrectomized rats.

Authors:  Frank T Spradley; John J White; William D Paulson; David M Pollock; Jennifer S Pollock
Journal:  Physiol Rep       Date:  2013-11-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.